drugset / Trial / NCT03250052
A Clinical Trial to Evaluate Pharmacokinetic Interactions and Safety Between Fimasartan and Linagliptin in Healthy Male Volunteers
RandomizedParallel-groupOpen-labelOther
Summary
The purpose of this study is to evaluate pharmacokinetic interactions and safety between fimasartan and linagliptin in healthy male volunteers.
Timeline
- Start
- 2017-08-14
- Primary completion
- 2017-10-13
- Completion
- 2017-11-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fimasartan | Small molecule | 120 mg | — |
| Subject | Linagliptin | Small molecule | 20 mg | — |